With hepatitis C virus infection, for instance, the distribution of the strength of interferon responsiveness across individuals quantitatively predicted the fraction of individuals that spontaneously cleared the infection [117,118] and together with the distribution of the CD8 T-cell response captured the success of interferon-based and other therapies [47,117–119]. The gene discussed is CD8A; the disease is hepatitis C virus infection.